Medivir AB (publ) (STO:MVIR)
1.044
-0.080 (-7.12%)
Nov 20, 2026, 5:29 PM CET
Medivir AB Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Medivir AB stock has an average price target of krĀ 3.95. The average 1-year stock price forecast is 278.35% higher than the current stock price, while the lowest is krĀ 3.80 (+263.98%) and the highest is krĀ 4.10 (+292.72%).
Price Target: krĀ 3.95 (+278.35%)
Analyst Consensus: n/a
Price Target
ChartAnalyst Ratings
There are currently no analyst ratings available for Medivir AB.
Recommendation Trends
| Rating | Mar '26 | May '26 | Jun '26 | Aug '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 0 | 0 |
Financial Forecast
Revenue This Year
4.40M
from 8.51M
Decreased by -48.27%
Revenue Next Year
4.50M
from 4.40M
Increased by 2.27%
EPS This Year
-0.13
EPS Next Year
-0.15
from -0.13
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SEK.